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        Periostin, which is an extracellular matrix (ECM) 
molecule of the fasciclin family, acts in cell adhe-
sion, migration, and growth in vitro (  1  –  6  ). In 
the heart, periostin is expressed at very early 
stages of embryogenesis; however, it is not de-
tected in the normal adult myocardium, except 
in the valves (  7, 8  ) and in the case of various heart 
diseases (  9  –  12  ). 
  The early cardiac healing process after acute 
myocardial infarction (AMI) can be divided into 
two successive phases: the infl  ammatory phase 
and the scar formation phase. In the infl  amma-
tory phase, monocytes and lymphocytes infi  ltrate 
into the necrotic myocardium, whereas in the 
scar formation phase, activated interstitial or 
circulating fi  broblasts increase their motility 
and migrate into the lesion. The activation of 
TGF      is important for regulation of this latter 
process. Myofi   broblasts expressing       smooth 
muscle actin (     SMA) induced by TGF      are 
specialized fi  broblasts that share characteristics 
with smooth muscle cells (SMCs). They play an 
important role in wound healing by synthesiz-
ing ECM and exerting strong contraction forces 
to minimize wound areas (  13  –  16  ). Regarding the 
infl   ammatory phase, recent knockout mouse 
studies indicated a positive association of in-
fl  ammatory factors with cardiac rupture or di-
lation (  17  –  23  ). However, in the scar formation 
phase, molecular analysis has been scant, except 
in respect to TGF     . To answer two important 
questions for both cardiologists and basic scien-
tists who are interested in pathological myocar-
dial healing, i.e.,   “  what regulates formation of 
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  Acute myocardial infarction (AMI) is a common and lethal heart disease, and the recruit-
ment of fi  broblastic cells to the infarct region is essential for the cardiac healing process. 
Although stiffness of the extracellular matrix in the infarct myocardium is associated 
with cardiac healing, the molecular mechanism of cardiac healing is not fully understood. 
We show that periostin, which is a matricellular protein, is important for the cardiac healing 
process after AMI. The expression of periostin protein was abundant in the infarct border 
of human and mouse hearts with AMI. We generated   periostin         /       mice and found no 
morphologically abnormal cardiomyocyte phenotypes; however, after AMI, cardiac healing 
was impaired in these mice, resulting in cardiac rupture as a consequence of reduced 
myocardial stiffness caused by a reduced number of      smooth muscle actin  –  positive cells, 
impaired collagen fi  bril formation, and decreased phosphorylation of FAK. These pheno-
types were rescued by gene transfer of a spliced form of periostin. Moreover, the inhibition 
of FAK or     v-integrin, which blocked the periostin-promoted cell migration, revealed that 
    v-integrin, FAK, and Akt are involved in periostin signaling. Our novel fi  ndings show the 
effects of periostin on recruitment of activated fi  broblasts through FAK-integrin signaling 
and on their collagen fi  bril formation specifi  c to healing after AMI. 296 PERIOSTIN IN INFARCT MYOCARDIUM | Shimazaki et al.
anterior descending artery (LAD) ligation (  24  ). Periostin pro-
tein was not observed up to day 2, but became detectable at 
day 3 in the areas showing infl  ammatory infi  ltration (  Fig. 1 D  ). 
This expression in the infarct LV increased signifi  cantly at day 4, 
and was still present at day 28 (  Fig. 1 D   and not depicted). 
To identify the cells producing periostin, we performed RNA 
in situ hybridization to detect   periostin       mRNA in the infarct LV 
wall of mice.   Periostin   mRNA was mainly expressed in fi  broblasts 
in both the infarct and noninfarct regions after AMI (  Fig. 1 E  ). 
To confi  rm the periostin expression in cardiac fi  broblasts, 
we performed RT-PCR analysis on purifi  ed cardiac cells, and 
these results showed the expression to be mainly in cardiac 
fi  broblasts, but not in cardiomyocytes (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20071297/DC1). 
Furthermore, these fi  broblasts were positive for      v-integrin, as 
indicated by fl  ow cytometry using cultured cardiac cells (Fig. S1). 
The mRNA of       ig-h3  , another fasciclin family member, which is 
also expressed in the embryonic heart (  25  ), was not observed in 
the scar phase of an ischemic injury?  ”   and   “  what is the nature 
of the factors responsible for the ventricular healing process af-
ter AMI?, ”   we focused on periostin, which is a TGF    -respond-
ing factor (  1  ). 
    RESULTS AND DISCUSSION   
  To assess the importance of periostin in the cardiac healing 
process, we examined the expression of human periostin pro-
tein in the myocardial tissue of the left ventricle (LV). No ex-
pression of it was observed in the normal myocardium (  Fig. 1 A  ), 
whereas immunoreactivity indicating periostin was detected in 
Azan-stained myocardial fi  brous areas from a patient with AMI 
(  Fig. 1, B and C  ), thus suggesting that periostin expression was 
induced in the infarct regions after AMI.   In the fi  brous area, 
strong immunoreactivity of periostin was observed around car-
diac fi  broblasts expressing      v-integrin, which is reported to be 
a receptor for periostin (  Fig. 1 C  ) (  2, 6  ). Next, we examined 
the expression of periostin in mice after AMI caused by left 
    Figure 1.     Periostin expression is induced after myocardial ischemia.   (A  –  C) Detection of periostin in myocardium from human patients. LV tissue 
from a patient with alcoholic cirrhosis (A) and from a patient with AMI (B and C). As seen by immunostaining, periostin protein was detected (B, right) in 
the myocardial area, which was shown to be fi  brous by Azan staining (B, left). Arrowheads in B indicate endocardium. (C) Comparison of the expression 
pattern between periostin (left) and      v-integrin (right) in the fi  brous area. (D  –  F) Periostin is up-regulated after AMI in mice. (D) Immunostaining of 
periostin after AMI. (E) Expression of   periostin   (top) and         ig-h3   mRNA (bottom) in the infarct LV wall of mice was analyzed by in situ hybridization. 
The dashed red line shows the infarct border. (F) Expression of spliced variant forms of periostin at various times after AMI. Periostin     b    e is indicated by 
the asterisk. Bars: (A) 25      m; (B) 2 mm; (C  –  E) 50     m.   JEM VOL. 205, February 18, 2008  297
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after AMI (50.26   ±   2.13 mmHg/100   μ  l in        /       vs. 65.08   ±   2.55 
mmHg/100   μ  l in   +/+  ; P = 0.001 ;   n   = 5;   Fig. 2 C  ). In contrast, 
no signifi  cant diff  erence was observed between   +/+   control 
noninfarct mice and   periostin         /       control noninfarct mice 
(maximum rupture pressure was 544.0   ±   6.93 mmHg in        /       vs. 
552.7   ±   7.86 mmHg in   +/+  ; P = 0.4546;   n   = 5; mean passive 
stiff  ness was 87.07   ±   4.41 mmHg/100   μ  l in        /       vs. 88.85   ±   
3.14 mmHg/100   μ  l in   +/+  ; P = 0.5985;   n   = 5). These biome-
chanical data indicate that both rupture threshold and passive 
stiff  ness in the LV of the   periostin         /       infarcted mice were signifi  -
cantly lower than those of the   +/+   mice after AMI, suggesting that 
the   periostin         /       infarct LV wall was more susceptible to cardiac 
rupture by mechanical stress. Although periostin defi  ciency 
did not aff  ect heart structure, the circulatory system, or cardiac 
performance under physiological conditions, periostin induced 
in the infarct myocardium appears to play a pivotal role in the 
healing process after AMI. 
  To confi  rm the histomorphological stiff  ness of the wall in 
  periostin         /       mice just escaping from rupture, we performed 
echocardiography 7 d after AMI, in addition to 1 d for heart 
tissue evaluation and 28 d for the analysis of chronic cardiac 
pathophysiology after AMI (  Fig. 2 D   and Table S1). Echo-
cardiographic measurements made 7 d after AMI showed de-
creases in left ventricular end-diastolic dimension (LVEDD) 
and left ventricular end-systolic dimension (LVESD) in   peri-
ostin         /       mice (  n   = 10), as compared with these parameters 
for   +/+   mice (  n   = 15; LVEDD and LVESD values for       /       were 
89.0 and 84.4%, respectively, of those for   +/+  ). These results 
demonstrate that the absence of periostin attenuated ventricular 
remodeling after AMI. To further examine tissue stiff  ness 
histologically, we performed toluidine blue staining, immuno-
fl  uorescence analysis using anti  –  collagen I, -fi  bronectin, and 
-vimentin antibodies, and transmission electron microscopic 
(TEM) observation of sections prepared from   periostin    +/+   and 
       /       mice 5 d after AMI. The results showed a lower number of 
cardiac fi  broblasts, along with sparser pericellular ECM density 
in the   periostin         /       mice than in the   +/+   mice (  Fig. 2, E and F  ); 
indeed, the number of vimentin-positive cardiac fi  broblasts 
was decreased in the infarct region of   periostin         /       mice 5 d af-
ter AMI (7,655   ±   148 cells/mm  2   in   +/+   vs. 6,913   ±   297 cells/
mm  2   in        /      ;   n   = 6; P   <   0.02;   Fig. 2 C  ). Furthermore, reduced 
collagen I and fi  bronectin immunoreactivity was observed in 
the infarct border of the        /       mice (  Fig. 2 F   and Fig. S3, available 
at http://www.jem.org/cgi/content/full/jem.20071297/DC1), 
and the collagen fi  ber cross-sectional area (CSA) in the in-
farct border of   periostin         /       mice was signifi  cantly smaller and 
more uniform than that of   +/+   mice 5 d after AMI (CSA of 
1,014.642   ±   17.546 nm  2   for the        /       and 2,233.780   ±   25.731 
nm  2   for the   +/+  ;   n   = 6; P   <   0.001, respectively;   Fig. 2 G  ). 
To confi  rm whether periostin defi  ciency aff  ected the bio-
chemical property of collagen after AMI, we evaluated the 
amount of collagen (hydroxyproline concentration, percentage 
of tissue dry weight) and nonreducible mature cross-links 
(mol pyridinoline per mol collagen) in the infarct zone 4 d after 
AMI. We detected a signifi  cant decrease in the collagen cross-
linking in the   periostin         /       mice, compared with the   +/+   mice 
the same regions ( Fig. 1 E ), thus suggesting the AMI-induced ex-
pression of fasciclin family molecules to be specifi  c to periostin. 
  Because we previously reported that several   periostin   tran-
scripts exist in human and mouse, caused by alternative splic-
ing at a 3      site (  1  ), we examined the expression of the splice 
variants in a time course experiment by RT-PCR analysis using 
three combinations of specifi  c primers (  Fig. 1 F  ). We observed 
four diff  erent isoforms, i.e.,      b (deletion of b domain),      e 
(deletion of e domain),      b     e (deletion of b and e domains), 
and Full (full-length), and we found that the pattern of splic-
ing depended on the time after AMI. Interestingly, one specifi  c 
spliced form,      b     e (  Fig. 1 F  , asterisk), was dominantly found as 
the lowest electrophoretic band in the initial stages (3, 4, and 5 d 
after AMI), indicating the involvement of      b     e periostin in 
the early healing stage of damaged tissues. By 28 d, all 4 iso-
forms were equally expressed. We also confi  rmed the expression 
of these isoforms at the protein level, and found the proteolytic 
modifi  cation of periostin during infarct healing (Fig. S1). 
  To investigate the role of periostin in AMI, we generated 
  periostin         /       mice combined with Cre recombination (  Fig. 2 A   
and Fig. S2, available at http://www.jem.org/cgi/content/
full/jem.20071297/DC1).   The embryogenesis of   periostin         /       
mice was apparently normal; and after the birth, the mice ap-
peared to be healthy. The observation of periostin in the de-
veloping heart prompted us to thoroughly investigate the heart 
structure and function in the   periostin         /       mice; however, no 
cardiomyocyte abnormalities were found in the myocardium, 
valve function, pulsation, or blood pressure in the 10-wk-old 
mice (Fig. S2 and not depicted), which is consistent with no 
signifi  cant expression in the adult myocardium. We then sub-
jected   periostin         /       mice to AMI by LAD ligation. There was 
no signifi  cant diff  erence in body weight or heart rate among 
       /      ,   +/      , and   +/+   in the normal control condition or after the 
AMI (Fig. S2, Table S1, and not depicted); moreover, there 
was no diff  erence in infarct size between the   periostin    +/+   and 
       /       mice after AMI (Table S1). However, the survival rate of 
  periostin         /       mice after AMI was signifi  cantly lower than that 
of   +/+   mice (17.58 vs. 53.76% at day 10; P   <   0.0001;   Fig. 2 B  ), 
whereas this rate of   periostin    +/       mice (55%) after AMI was similar 
to that of   +/+   mice. The incidence of mortality in   periostin         /       
mice, mainly caused by cardiac rupture, which occurred within 
7 d, was signifi  cantly higher (P   <   0.001) than that of   +/+   mice: 
62/91 (68.1%) in        /       versus 25/80 (31.3%) in   +/+   (  Fig. 3 C  ), 
whereas this frequency of   +/       mice 6/20 (30%) was similar to 
that of   +/+   mice. Thereafter, these survival rates reached a pla-
teau from 8 d up to 4 wk after AMI (unpublished data). To test 
whether the increased rate of cardiac rupture was caused by 
abnormal LV wall stiff  ness, we analyzed the rupture threshold 
stiff  ness of the LVs of   periostin         /       and   +/+   mice 4 d after AMI 
by conducting an LV distending pressure/rupture threshold 
study (  18  ). Myocardial tearing was found at the infarct border 
in all the ruptured LVs, and the mean of the maximum rup-
ture pressure was signifi  cantly lower in   periostin         /       mice than 
in   +/+   mice after AMI (312.7   ±   3.2 mmHg in        /       vs. 374.3   ±   
5.8 mmHg in   +/+  ; P = 0.0008;   n   = 5), and the mean passive 
stiff  ness was also signifi  cantly lower in        /       mice than in   +/+   mice 298 PERIOSTIN IN INFARCT MYOCARDIUM | Shimazaki et al.
    Figure 2.     Cardiac rupture after AMI is caused by   periostin   disruption.   (A) Schema of the targeting strategy deletes the fi  rst exon of   periostin   locus. 
(B) Decreased survival of   periostin      /      mice  ( n   = 91) compared with the survival of   +/+   mice  ( n   = 80) after AMI. **, P   <   0.0001. (C) Infarct LV wall stiffness 
was more reduced in   periostin      /      mice than in   +/+   mice after AMI (left). Mean passive stiffness was also signifi  cantly lower in the       /      mice than in the 
  +/+   mice after AMI (right). Open columns,   +/+ ;  fi  lled columns,       /     . **, P   <   0.005, compared with   +/+   mice. (D) Loss of periostin attenuated cardiac dilation after 
AMI, as shown by echocardiography. Open columns,   +/+ ;  fi  lled columns,       /     . *, P   <   0.05 compared with   +/+   mice. (E) Histological analysis of heart sections 
from   periostin      /      and   +/+   mice stained with toluidine blue 5 d after AMI, showing a lower number of cardiac fi  broblasts and lower ECM density in       /      mice. 
(right) The number of vimentin-positive cells. *, P   <   0.02, compared with   +/+   mice. (F) Images of the infarct border stained with anti-collagen I (left), and 
TEM images of infarct border, showing evidence of smaller and less abundant collagen in tissues from   periostin      /      mice 5 d after AMI compared with the 
collagen of the   +/+   infarct heart. Bar, 50      m. (G) CSA distribution of collagen fi  brils in the infarct border of   +/+   and       /      mice, measured from TEM images. 
(H) Biochemical analysis of the collagen amount and cross-linking. *, P   <   0.05; **, P   <   0.01, compared with   +/+   mice. (I) The number of     SMA-positive 
cells in the infarct area was reduced in   periostin      /      mice 5 d after AMI. (right) The number of      SMA-positive cells. **, P   <   0.01, compared with   +/+   mice. 
Error bars represent the mean   ±   the SEM. Bars, 200     m.   JEM VOL. 205, February 18, 2008  299
BRIEF DEFINITIVE REPORT
However, the number of cells positive for SM1, which is 
a specifi  c marker of SMCs, was not signifi  cantly diff  erent, 
and almost all of the      SMA-positive cells were SM1 nega-
tive (unpublished data). These results indicate that not the 
infl  ammatory cell recruitment, but rather the recruitment 
of cardiac fi  broblasts in the infarct region, was impaired in 
these animals. 
  To determine whether the impaired cardiac healing in 
response to AMI could be restored by periostin directly, we per-
formed a rescue experiment by using      b     e, which is the main 
periostin isoform detected early after AMI. The   periostin         /       
mice were treated with a recombinant adenovirus expressing 
periostin (Ad-     b     e) or with a control adenovirus (Ad-nls; 
nuclear localization signal-LacZ). In the control experiment, 
the Ad-nls-LacZ transfer was detected in the infarct border 
at 4 d after AMI by whole-mount X-gal staining, proving 
the experimental feasibility (  Fig. 3 A  ).   In   periostin         /       mice 
infected with Ad-     b     e, we fi  rst confi  rmed expression of 
transferred periostin in the infarct tissue by immunoblot and 
immunofl  uorescence analyses ( Fig. 3 B  and Fig. S4, available at 
http://www.jem.org/cgi/content/full/jem.20071297/DC1), 
and then observed an increase in the area reactive with anti-
     SMA antibody compared with that area of the control Ad-nls-
LacZ  –  infected   periostin         /       mice (597   ±   107 cells/mm  2   in 
Ad-nls-LacZ  –  infected        /       mice vs. 1,535   ±   197 cells/mm  2   
(1.555   ±   0.461 in        /      ,   n   = 4, vs. 6.433   ±   0.919 in   +/+  ,   n   = 7; 
P = 0.0043;   Fig. 2 H  ). Moreover, the   periostin         /       infarct LV 
tissue exhibited 52.9% less collagen content compared with 
the   +/+   tissue (7.832   ±   2.241% in        /      ,   n   = 4, vs. 14.795   ±   
1.565% in   +/+  ,   n   = 7; P = 0.0283;   Fig. 2 H  ). In normal heart 
tissues from mice of either genotype, the collagen amount 
was under the detection level by our methods (unpublished 
data), indicating that the detected collagen was newly pro-
duced after AMI. In conclusion, we observed the alterations 
of collagen structure in the   periostin         /       mice; they were smaller 
and more uniform, with the decreased amount and cross-linking 
of collagen eff  ecting lower stiff  ness. These results suggest that 
periostin expression contributed signifi  cantly to the amount or 
cross-linking of newly synthesized collagen, which is essential 
for the normal mechanical properties of collagen-containing 
tissues after MI. These fi  ndings indicate that impaired colla-
gen fi  ber formation occurred in   periostin         /       mice after AMI. 
Interestingly, although the total activity of myeloperoxidase 
and the numbers of Mac-3  –  positive infl  ammatory cells, ki67-
positive proliferating cells, and active caspase-3  –  positive 
apoptotic cells in the infarct border were not signifi  cantly dif-
ferent between   +/+   and        /       mice (not depicted), we observed 
a lower number of      SMA-positive cells in the infarct area 
of   periostin         /       mice 5 d after AMI (1,792   ±   193 cells/mm  2   
in   +/+   vs. 758   ±   75 cells/mm  2   in        /      ; P   <   0.01;   n   = 6;   Fig. 2 I  ). 
    Figure 3.     Adenovirus-mediated periostin     b    e gene transfer prevents cardiac rupture in the   periostin        /      mice.   (A) Whole-mount X-gal staining 
4 d after AMI showed strong expression in the border of the Ad-nls-LacZ  –  infected myocardial infarct (arrowheads). The arrow indicates the ligated 
portion. (B) Western blot analysis for Ad-    b   e – infected   periostin      /      infarct LV. (C) Infection with Ad-    b    e reversed the high incidence of cardiac rupture 
in the   periostin      /      mice to a lower level, comparable to the incidence in the   +/+   mice. *, P   <   0.02; **, P   <   0.001, compared with control Ad-treated       /      mice. 
(D) Compared with the Ad-nls-LacZ  –  infected   periostin      /      hearts, the Ad-    b    e  –  infected hearts increased the number of      SMA-positive cells 5 d after 
AMI. (right) the number of      SMA-positive cells. **, P   <   0.01, compared with the mock infection of the       /      mice. Error bars represent the mean   ±   the SEM. 
Bars, 200     m.   300 PERIOSTIN IN INFARCT MYOCARDIUM | Shimazaki et al.
Akt was reduced, and only a small amount of phosphorylated 
FAK was detected in the border of the   periostin         /       infarcted 
mice (  Fig. 4, A and B,   and Fig. S5).   
  To further investigate the role of periostin in FAK activa-
tion and cell motility, we performed immunofl  uorescence 
staining for phosphorylated-FAK and rhodamine-phalloidin 
staining for the actin cytoskeleton in an embryonic mesenchy-
mal cell line, C3H10T1/2, treated or not with periostin      b     e. 
The presence of periostin      b     e changed the cytoskeletal 
arrangement and motility of the cells, resulting in dynamic 
protrusion of their processes (  Fig. 4 C  ). In a time-course 
in Ad-     b     e  –  infected        /       mice; P   <   0.01;   n   = 6;   Fig. 3 D  ). 
Furthermore, the Ad-     b     e infection reduced the incidence 
of rupture frequency in   periostin         /       mice (35.0%) compared 
with that for the Ad-nls-LacZ  –  treated      /      mice (65.0%; 
  Fig. 3 C  ). These results demonstrate that periostin      b     e was 
essential for in vivo recruitment of      SMA-positive fi  broblasts 
to block rupture after AMI. As cell motility and morphology of 
fi  broblasts are associated with the expression of the phosphory-
lated forms of Akt and focal adhesion kinase (FAK) (  26, 27  ), 
we examined the phosphorylation of these proteins in the 
infarct border 5 d after AMI. The amount of phosphorylated 
    Figure 4.     Periostin promotes cell migration through integrin-mediated FAK signaling.   (A) Phosphorylation of FAK in infarct LV from   periostin  +/+  
mice and       /      mice 5 d after AMI. (B) Immunofl  uorescence for phosphorylated FAK (p-FAK  Y397  ) in the border of infarct LV from   periostin  +/+   mice and       /     
mice 5 d after AMI. Merged images show an overlay of p-FAK  Y397   (green) and propidium iodide  –  stained nuclei (red). The dotted line shows the infarct 
border. NIZ, noninfarct zone; IZ, infarct zone. (C and D) Promotion of cell spreading and activation of FAK phosphorylation in vitro. The morphology of 
starved C3H10T1/2 cells was analyzed by immunofl  uorescence 12 h after adding periostin     b    e (C), and the p-FAK  Y397   was examined by Western blot 
analysis at various times after adding periostin     b    e (D). In C, the merged images show an overlay of p-FAK  Y397   (green) and rhodamine-phalloidin (red), 
and the arrows point to FAK phosphorylation sites. The insets show higher magnifi  cation of the cell processes. (E) Chemotaxis of primary cardiac fi  bro-
blasts from   periostin      /      mice in the absence (mock) or presence of periostin     b    e, detected by an in vitro cell migration assay. Cardiac fi  broblasts were 
signifi  cantly activated by periostin     b    e, and treatment with neutralizing antibodies against periostin and      v-integrin, PP2, or FAK siRNAs reduced the 
cell migration. **, P   <   0.001 vs. periostin     b    e. Error bars represent the mean   ±   the SEM. (F) Periostin can stimulate FAK and Akt phosphorylation through 
integrin signaling. Starved C3H10T1/2 cells were incubated for 1 h with periostin     b    e with or without each siRNA or the FAK and Akt inhibitors. 
Bars: (B) 100      m; (C) 20     m.   JEM VOL. 205, February 18, 2008  301
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       /       mice; TGF      also enhanced the periostin expression in the 
infarct border after AMI because anti-TGF      antibody treat-
ment blocked the periostin expression (Fig. S6, available at 
http://www.jem.org/cgi/content/full/jem.20071297/DC1). 
The expression of both TGF      and periostin is up-regulated by 
angiotensin II and attenuated by angiotensin receptor blockers 
after AMI (  29, 30  ), suggesting that periostin may play a role 
via angiotensin II-TGF      signaling. The combined results on 
the biomechanical properties and the collagen content of the 
isolated infarct heart support the concept that the periostin-
linked collagen fi  brous skeleton is an important determinant 
of cardiac rupture. 
  The results given here indicate that periostin signals acti-
vate cell migration of cardiac fi  broblasts from outside into the 
infarct region through FAK phosphorylation, and then the 
migrated cells diff  erentiate into      SMA-positive fi  broblasts, re-
sulting in strengthening of the stiff  ness of the LV wall through 
collagen synthesis after AMI. FAK is known to be involved in 
tyrosine phosphorylation during integrin-mediated signaling, 
and this molecule plays an important role in the response of 
migrating cells to mechanical stress (  31  ). Recently, FAK has 
been implicated as a downstream target associated with angio-
tensin II  –  stimulated cell migration (  32  ). The mechanism un-
derlying the periostin action of promoting the recruitment of 
cardiac fi  broblasts followed by healing of the infarct region 
appears to involve activation of the FAK pathway, indicating 
that the periostin-induced increase in FAK phosphorylation in 
the infarct myocardium enhanced the motility of these fi  bro-
blasts. In contrast, three-dimensional culture studies imply that 
the matrix stiff  ness regulates cell fate by modulating integrin 
signaling (  31, 33  ). Considering these accumulated results, we 
suggest that periostin is mainly produced by fi  broblasts through 
angiotensin II  –  TGF      signaling and may convey pathologi-
cally rapid reinforced mechanical signals to FAK-integrin sig-
naling after AMI. The fi   broblastic cells activated by these 
signals secrete periostin, which in turn increases their motility, 
contractility, and synthesis of ECM proteins, thus promoting 
further recruitment and activation of fi  broblasts. Periostin may 
serve as the trigger of these feedback mechanisms in the ongo-
ing healing processes. Additional studies to elucidate in more 
detail the characteristics of cardiac fi  broblasts may lead to a 
deeper understanding of the role of periostin after AMI, as 
well as aid in identifying the molecular targets of therapies to 
augment cardiac performance and wall stiff  ness after AMI. 
    MATERIALS AND METHODS   
  Preparation of rabbit polyclonal antibodies against periostin.     We 
raised polyclonal RD1 antibodies against periostin by using the peptide 
DNLDSDIRRGLESNVN (representing aa 143  –  158 of human periostin) for 
human periostin and the peptide ENLDSDIRRGLENNVN (representing 
aa 145  –  160 of mouse periostin) for mouse periostin. The antibodies were 
affi   nity-purifi  ed by using the respective immunogenic peptide. 
  Histology, immunostaining, and electron microscopy.     Human tissue 
samples were obtained during autopsy and fi  xed in 4% neutral formalin or 
20% formalin. A total of 41 cases, ranging from a fetus to an 89-yr-old pa-
tient, including 15 cases of myocardial infarction, were examined. All the 
cases were approved for use in research by the Ethics Committee of the 
experiment, periostin      b     e continuously activated the phos-
phorylation of FAK for 9 h after the addition of it to serum-
starved cell cultures, whereas in the control, the signal had 
decreased by 6 h (  Fig. 4 D  ). These results demonstrate that 
periostin      b     e activated FAK phosphorylation and promoted 
formation of dynamic protrusions. Next, we tested the motil-
ity of primary cardiac fi  broblasts from   periostin         /       mice in the 
presence of periostin      b     e. The result showed that periostin 
     b     e strongly activated the cell migration of these fi  broblasts 
(  Fig. 4 E  ). Moreover, this migration caused by periostin      b     e 
was signifi  cantly reduced by antibodies against either periostin 
or      v-integrin; by PP2, which is known as a compound that 
specifi  cally inhibits adhesion-induced FAK phosphorylation (  28  ); 
and by knockdown of FAK by siRNA (  Fig. 4 E  ), suggesting 
that periostin      b     e would activate the cell motility of their 
fi  broblasts by FAK signaling through      v-integrin in mice sub-
jected to AMI. Finally, we inhibited the integrin-mediated 
FAK pathway by using chemical compounds and siRNAs 
(  Fig. 4 F  ). FAK inhibitors or siRNA down-regulated the Akt 
phosphorylation, and Akt inhibitors did not change FAK 
phosphorylation after stimulation by periostin      b     e, indicat-
ing that Akt is a downstream molecule of FAK and periostin 
     b     e. Moreover,      v-integrin siRNA treatment blocked both 
FAK and Akt phosphorylation after stimulation by periostin 
     b     e. These results indicate that periostin      b     e can stimulate 
FAK and Akt phosphorylation through      v-integrin. 
  We demonstrated that in the case of periostin defi  ciency, 
the collagen amount was reduced in the infarct myocardium, 
resulting in frequent cardiac rupture in the AMI. Our results, 
together with the previous fi  ndings by Norris et al. (  7  ) on the 
role of periostin in collagen fi  brillogenesis of skin and tendon, 
strongly suggest that fi  brillar collagen formation, which con-
tributes essentially to a mechanically stable scar formation, was 
impaired in the early stage of MI in the periostin defi  ciency, 
resulting in a high rate of cardiac rupture. Furthermore, we 
have found that the reduced mechanical strength, rupture of 
the infarct region, and repression of LV dilation in periostin 
defi  ciency were most likely caused by a reduced number of 
cardiac fi  broblasts and by the insuffi   cient creation of a durable 
collagen network caused by a lower rate of collagen synthesis 
and cross-linking. To reveal more about the importance of 
collagen production or collagen cross-linking for protection 
against heart rupture, after AMI, we treated mice with an in-
hibitor of lysyl oxidase, thus inhibiting collagen cross-linking. 
Interestingly, the data showed a high amount of collagen pro-
duction with a larger number of vimentin-positive cells in the 
infarct region, resulting in eff  ective blockage of heart rupture 
(unpublished data). These data suggest that periostin-stimulated 
migration of cardiac fi  broblasts into the infarct region, the cells 
of which produce a high amount of collagen, is more essential 
than collagen cross-linking by periostin. 
  The expression of TGF     was markedly up-regulated in the 
infarct border during the scar formation phase after AMI, and 
the phosphorylation of smad 2/3 was consequently increased 
(unpublished data), whereas there was no signifi  cant diff  er-
ence in the TGF      transcription level between   periostin    +/+   and 302 PERIOSTIN IN INFARCT MYOCARDIUM | Shimazaki et al.
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